70
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Cochleate Delivery Vehicles: Applications in Vaccine Delivery

, , &
Pages 339-358 | Published online: 28 Sep 2008

References

  • New Generation Vaccines, 2nd Edition, M. M. Levine, G. C. Woodrow, J. B. Kaper, G. S. Cobon. Marcel Dekker, Inc., New York, NY 1997
  • Vaccine Design: The Subunit and Adjuvant approach, M. F. Powell, M. J. Newman. Plenum Press, New York, NY 1995
  • McGhee J. R., Mestecky J., Dertzbaugh M. T., Eldridge J. H., Hirasawa M., Kiyono H. The mucosal immune system: From fundamental concepts to vaccine development. Vaccine 1992; 10: 75–88
  • McGhee J. R., Czerkinsky C., Mestecky J., Vaccines Mucosal. An Overview. Mucosal Immunology, 2nd Edition, P. Ogra, J. Mestecky, M. Lamm, W. Strober, J. R. McGhee, J. Bienenstock. Marcel Dekker, Inc., New York, NY 1998
  • Walker R. I. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 1994; 12: 387–396
  • Mannino R. J., Gould-Fogerite S. Lipid matrix-based vaccines for mucosal and systemic immunization. Vaccine Design: The Subunit and Adjuvant Approach, M. F. Powell, M. J. Newman. Plenum Press, New York, NY 1995; 363–387
  • Gould-Fogerite S., Mannino R. J. Mucosal and systemic immunization using cochleate and liposome vaccines. J Lipo Res 1996; 6: 357–379
  • Mannino R. J., Gould-Fogerite S. Antigen cochleate preparations for oral and systemic vaccination. New Generation Vaccines, 2nd Edition, M. M. Levine, G. C. Woodrow, J. B. Kaper, G. S. Cobon. Marcel Dekker, Inc., New York, NY 1997; 229–237
  • Gould-Fogerite S., Kheiri M. T., Zhang F., Wang Z., Scolpino A., Feketeova E., Canki M., Mannino R. J. Targeting immune response induction with cochleate and liposome-based vaccines. Adv Drug Del Rev 1998; 32: 273–287
  • Michalek S. M., O'Hagen D. T., Gould-Fogerite S., Osterhaus A. D.M.E., Rimtnelzwaan G. F. Antigen Delivery Systems: Nonliving Microparticles, Liposomes, Cochleates, and ISCOMS. Mucosal Immunology, 2nd Edition, P. Ogra. Marcel Dekker, New York, NY 1998; 759–778
  • Gould-Fogerite S., Mannino R. J. Cochleates for Induction of Mucosal and Systemic Immune Responses. Methods in Molecular Medicine, Vol 42, Vaccine Adjuvants: Preparation Methods and Research Protocols, D. T. O'Hagan. Humana Press, Totowa, NJ 2000; 179–196
  • Gould-Fogerite S., Mannino R. J. Targeted fusogenic liposomes: Functional reconstitution of membrane proteins into large unilamellar vesicles via protein-cochleate intermediates. Liposome Technology, Vol III, 2nd Edition, G. Gregoriadis. CRC Press, Inc, Boca Raton, Florida 1992; 262–275, Chapter 17
  • Pride M., Natuk R. J., Gould-Fogerite S., York L., Giorgio D., She J., Chen D., Lu R., Wang Z., Mannino R. J., Eldridge J. H., Mishkin E. M. Immunogenicity of Cochleates Containing Plasmid gD DNA and Plasmid Murine IL-12 DNA. Keystone Symposia, DNA Vaccines, Snowbird, Utah, 1999
  • Zarif L., Graybill J. R., Perlin D., Najvar L., Bocanegra R., Mannino R. J. Antifunal activity of amphotericin B cochleates against Candida albicans infection in a mouse model. Antimicrobial Agents and Chemotheraphy 2000; 44(6)1463–1469
  • Papahadjopoulos D., Vail W. J., Jacobson K., Poste G. Cochleate lipid cylinders: Formation by fusion of unilamellar lipid vesicles. Biochim Biophys Acta 1975; 394: 483–490
  • Gould-Fogerite S., Mannino R. J. Rotary dialysis: Its application to the production of large liposomes and large proteoliposomes (protein-lipid vesicles) with high encapsulation efficiency and efficient reconstitution of membrane proteins. Anal Biochem 1985; 148: 15–25
  • Gould-Fogerite S., Mazurkiewicz J. E., Bhisitkul D., Mannino R. J. The reconstitution of biologically active glycoproteins into large liposomes: Use as a delivery vehicle to animal cells. Advances in Membrane Biochemistry and Bioenergetics, C. H. Kim, J. Diwan, H. Tedeschi, J. J. Salerno. Plenum Publishing Corp., New York, NY 1987; 569–586
  • Gould-Fogerite S., Mazurkiewicz J., Lehman J., Raska K., Jr., Voelkerding K., Mannino R. J. Chimerasome-mediated gene transfer in vitro and in vivo. Gene 1989; 84: 429–438
  • Miller M. D., Gould-Fogerite S., Shen L., Woods R. M., Koenig S., Mannino R. J., Letvin N. Vaccination of Rhesus Monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes. J Exp Med 1992; 176: 1739–1744
  • Gregoriadis G. Immunological adjuvants: A role for liposomes, Immunol. Today 1990; 11: 89–97
  • Pappahadjopoulos D., Nir S., Duzgunes. Molecular mechanisms of calcium-induced membrane fusion. (Review) J of Bioenergetics & Biomembranes 1990; 22: 157–79
  • Peterson G. L. Modified Lowry procedure for protein determination. Anal Biochem 1977; 83: 346–356
  • Wilson J. A., Cox N. J. Structural basis of immune recognition of influenza virus hemagglutinin. Ann Rev Immunol 1990; 8: 737–771
  • Parker G., Peng B., He M., Gould-Fogerite S., Chou C, Raveche E. S. In vivo and in vitro antiproliferative effects of antisense interleukin 10 oligonucleotides. Methods in Enzymology, Ian Phillips, 1999; Vol 314: 411–429
  • McMichael A. J., Gotch F. M., Noble G. R., Beare P. A.S. Cytotoxic T-cell immunity to influenza. N Engl J Med 1983; 309: 13–17
  • Safrit J. T., Andrews C. A., Zhu T., Ho D. D., Koup R. A. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: Recognition of autologous virus sequences within a conserved immunodominant epitope. J Exp Med 1994; 179: 463–72
  • Creutz C. E. The annexins and exocytosis. Science 1992; 258: 924–31
  • Zarif L., Brois D., Chen Z. W., Zhang F., Gould-Fogerite S., Mannino R. J. Utilization of Cochleates for the delivery of genetic material in vivo. Cancer Gene Therapy, H. Mazarakis, S. J. Swart. Library Series, IBC, Southborough 1997; 77–89
  • Allen P. M. Antigen processing at the molecular level. Immunol Today 1987; 8: 270–273
  • Gould-Fogerite S., Cottler-Fox, Mannino R. J., Margolis D. Stable Gene transfer to CD34+ cells augmented by coordinated non-viral delivery of AAV components. American Society of Gene Therapy, 2nd Ann. Mtg., Washington, DC, June 9–13, 1999

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.